课题基金 / 基金详情

Cardiac Risk Factors in Chronic Kidney Disease

Cardiac Risk Factors in Chronic Kidney Disease
慢性肾脏病的心脏危险因素
批准号:
7049419
负责人:
MARK J SARNAK
金额:
$23.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-03-31

项目摘要

项目成果

MARK J SARNAK的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chronic kidney disease (CKD) is a major public health problem with as many as 20 million affected individuals in the US. Cardiovascular disease (CVD) is the primary cause of morbidity and mortality in CKD, and the presence of CKD is now recognized as an independent risk factor for development of CVD. The mechanism through which CKD increases CVD risk is however not well understood. Patients with CKD may be at increased risk for CVD because they may have an increased prevalence and severity of traditional risk factors, as defined by the Framingham population. Patients with CKD, are however, also exposed to a vast array of novel CVD factors, that increase in prevalence as kidney function declines (non traditional risk factors). There are few studies, however, that have evaluated the relative importance of traditional and non-traditional risk factors in patients with CKD. The Framingham coronary risk score uses a composite of traditional CVD risk factors to estimate the risk for incident coronary heart disease (CHD) in the general population. The risk score, has not however, been evaluated in prospective studies of patients with CKD. We propose to pool subjects with CKD, defined by an estimated glomerular filtration rate of 15 to 60 ml/min/1.73 m2, in two well-characterized cohorts: the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study. This pooled CKD cohort is representative of the US population with CKD. Our general hypothesis is that the Framingham coronary risk score will not accurately predict CHD events in patients with CKD. Our specific aims are as follows. 1. To evaluate risk factors for CHD, cerebrovascular disease and all-cause mortality in 1678 subjects with CKD. 2. To compare the relative risk ascribed to each traditional risk factor in patients with CKD with that in the Framingham population, and to evaluate the discriminatory capacity and the calibration potential of the. Framingham coronary risk score to predict incident myocardial infarction (MI)/fatal CHD in 1105 subjects with CKD but without CVD. 3. To develop and evaluate a new prediction equation for Ml/fatal CHD in CKD utilizing both traditional and non-traditional factors. Achievement of the aims outlined is realistic. Statistical analyses reveal adequate power to evaluate each of the aims. Evaluating the importance of traditional and non-traditional risk factors in CKD is essential in that it will focus attention on the most important cardiac risk factors in this population.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Measures of blood pressure and cognition in dialysis patients.
透析患者的血压和认知度量。
DOI: 10.1111/j.1542-4758.2012.00718.x
发表时间: 2013-01
期刊: Hemodialysis international. International Symposium on Home Hemodialysis
影响因子: --
作者: [Giang LM, Tighiouart H, Lou KV, Agganis B, Drew DA, Shaffi K, Scott T, Weiner DE, Sarnak MJ]
通讯作者: Sarnak MJ
DOI: 10.1186/s12882-017-0628-0
发表时间: 2017-07-05
期刊: BMC nephrology
影响因子: 2.3
作者: [Drew DA, Koo BB, Bhadelia R, Weiner DE, Duncan S, la Garza MM, Gupta A, Tighiouart H, Scott T, Sarnak MJ]
通讯作者: Sarnak MJ
DOI: 10.1053/j.ajkd.2010.04.018
发表时间: 2010-10
期刊: American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子: --
作者: [Agganis BT, Weiner DE, Giang LM, Scott T, Tighiouart H, Griffith JL, Sarnak MJ]
通讯作者: Sarnak MJ
DOI: 10.1186/1471-2369-10-26
发表时间: 2009-09-17
期刊: BMC nephrology
影响因子: 2.3
作者: [Weiner DE, Krassilnikova M, Tighiouart H, Salem DN, Levey AS, Sarnak MJ]
通讯作者: Sarnak MJ
8
    Cognition and Dialysis
    • 批准号:
      7762764
    • 项目类别:
    • 资助金额:
      $23.71万
    • 财政年份:
      2008
    • 负责人:
      MARK J SARNAK
    • 依托单位:
    Cognition and Dialysis
    • 批准号:
      8018539
    • 项目类别:
    • 资助金额:
      $26.83万
    • 财政年份:
      2008
    • 负责人:
      MARK J SARNAK
    • 依托单位:
    Does Raising HDL-C with Niacin Improve Endothelial Function in Early CKD?
    • 批准号:
      7612743
    • 项目类别:
    • 资助金额:
      $19.8万
    • 财政年份:
      2008
    • 负责人:
      MARK J SARNAK
    • 依托单位:
    Cognition and Dialysis
    • 批准号:
      7557838
    • 项目类别:
    • 资助金额:
      $30.79万
    • 财政年份:
      2008
    • 负责人:
      MARK J SARNAK
    • 依托单位: